DE69432751D1 - Präparation und stabilisation von zellen - Google Patents

Präparation und stabilisation von zellen

Info

Publication number
DE69432751D1
DE69432751D1 DE69432751T DE69432751T DE69432751D1 DE 69432751 D1 DE69432751 D1 DE 69432751D1 DE 69432751 T DE69432751 T DE 69432751T DE 69432751 T DE69432751 T DE 69432751T DE 69432751 D1 DE69432751 D1 DE 69432751D1
Authority
DE
Germany
Prior art keywords
blood
leucocytes
composition
stabilizing
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69432751T
Other languages
English (en)
Other versions
DE69432751T2 (de
Inventor
Vivian Granger
David Barnett
John Tennison Reilly
Petra Susanne Maria Mayr
Shawn Patrick Fay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHEFFIELD TEACHING HOSPITALS
Original Assignee
SHEFFIELD TEACHING HOSPITALS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939313962A external-priority patent/GB9313962D0/en
Priority claimed from GB9406698A external-priority patent/GB9406698D0/en
Application filed by SHEFFIELD TEACHING HOSPITALS filed Critical SHEFFIELD TEACHING HOSPITALS
Application granted granted Critical
Publication of DE69432751D1 publication Critical patent/DE69432751D1/de
Publication of DE69432751T2 publication Critical patent/DE69432751T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002—Partitioning blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
DE69432751T 1993-07-05 1994-07-05 Präparation und stabilisation von zellen Expired - Fee Related DE69432751T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB939313962A GB9313962D0 (en) 1993-07-05 1993-07-05 Preparation and stabilisation of leucocytes
GB9313962 1993-07-05
GB939315871A GB9315871D0 (en) 1993-07-05 1993-07-20 Preparation and stabilisation of leucocytes
GB9315871 1993-07-20
GB9406698A GB9406698D0 (en) 1994-04-05 1994-04-05 Preparation and stabilisation of cell suspensions
GB9406698 1994-04-05
PCT/EP1994/002189 WO1995001796A1 (en) 1993-07-05 1994-07-05 Preparation and stabilisation of cells

Publications (2)

Publication Number Publication Date
DE69432751D1 true DE69432751D1 (de) 2003-07-03
DE69432751T2 DE69432751T2 (de) 2004-04-29

Family

ID=27266764

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0708649T Pending DE708649T1 (de) 1993-07-05 1994-07-05 Präparation und stabilisation von zellen
DE69432751T Expired - Fee Related DE69432751T2 (de) 1993-07-05 1994-07-05 Präparation und stabilisation von zellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE0708649T Pending DE708649T1 (de) 1993-07-05 1994-07-05 Präparation und stabilisation von zellen

Country Status (14)

Country Link
US (2) US6197540B1 (de)
EP (1) EP0708649B1 (de)
JP (1) JPH09503051A (de)
AT (1) ATE241368T1 (de)
AU (2) AU700699B2 (de)
BR (1) BR9407003A (de)
CA (1) CA2166729A1 (de)
DE (2) DE708649T1 (de)
ES (1) ES2197168T3 (de)
FI (1) FI960045A0 (de)
GB (1) GB2279653B (de)
NO (1) NO960049L (de)
NZ (1) NZ271318A (de)
WO (1) WO1995001796A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2166729A1 (en) 1993-07-05 1995-01-19 Vivian Granger Preparation and stabilisation of cells
DE69504646T2 (de) * 1994-04-05 1999-04-29 North Gen Hospital Nhs Trust Herstellung und stabilisierung von zellsuspensionen
GB2313288B (en) 1996-05-24 2000-07-12 North Gen Hospital Nhs Trust Specimen collection fluid
EP1182457A1 (de) * 2000-08-17 2002-02-27 Mallinckrodt Baker B.V. Verfahren und Reagens zur Analyse von Blutproben, im besonderen für tierärztliche Anwendungen
US6913932B2 (en) * 2002-08-23 2005-07-05 Beckman Coulter, Inc. Formaldehyde-ammonium salt complexes for the stabilization of blood cells
CA2445204C (en) * 2002-10-16 2014-08-12 Streck Laboratories, Inc. Method and device for collecting and preserving cells for analysis
US7267980B1 (en) 2003-04-04 2007-09-11 Research & Diagnostic Systems, Inc. Stabilizing solution for cells and tissues
US20050085028A1 (en) * 2003-10-21 2005-04-21 International Business Machines Corporation Method and structure to suppress external latch-up
CN100376669C (zh) * 2005-02-25 2008-03-26 深圳迈瑞生物医疗电子股份有限公司 生物红细胞体积长期稳定的处理方法
US20070015134A1 (en) * 2005-07-15 2007-01-18 Beckman Coulter, Inc. Quantitative stabilized cell reference control products and methods
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
EP2316036B1 (de) * 2008-07-11 2013-12-25 The Secretary of State for Health Stimulierte zellstandards
WO2010078194A1 (en) 2008-12-30 2010-07-08 Streck, Inc. Method for screening blood using a preservative that may be in a substantially solid state form
US11634747B2 (en) * 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
NO2398912T3 (de) 2009-02-18 2018-02-10
WO2011057184A1 (en) * 2009-11-09 2011-05-12 Streck, Inc. Stabilization of rna in and extracting from intact cells within a blood sample
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
AU2011255641A1 (en) 2010-05-18 2012-12-06 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
CA2917912C (en) 2013-07-24 2019-09-17 Streck, Inc. Compositions and methods for stabilizing circulating tumor cells
RU2717641C2 (ru) 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
WO2018022991A1 (en) 2016-07-29 2018-02-01 Streck, Inc. Suspension composition for hematology analysis control
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CA3050906A1 (en) 2017-01-22 2018-07-26 Chryos, Llc Composition and method of use of the same for preserving cells for analysis
WO2019210306A1 (en) * 2018-04-27 2019-10-31 Momenta Pharmaceuticals , Inc. Blood preparation
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
CN113325171B (zh) * 2021-08-02 2021-12-21 天津康博尔生物基因技术有限公司 检测人体红细胞叶酸含量的试剂盒、检测方法及用途

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068862B (de) 1957-05-03 1959-11-12 Penicillin-Gesellschaft Dauelsberg a Co., Göttingen Verfahren zur Verlängerung der Haltbarkeit von Blutkonserven
DE1147004B (de) * 1959-10-16 1963-04-11 Dr Med Herbert Fischer Verfahren zur Konservierung von lebenden menschlichen oder tierischen Zellpraeparaten, insbesondere von Blut und Blutbestandteilen
CA933092A (en) * 1969-04-10 1973-09-04 V. Collins Zeola Method of prolonging the viability of lymphocytes
FR2202688B1 (de) 1972-10-17 1977-04-15 Cepbepe
US4045488A (en) 1974-11-06 1977-08-30 Pfizer Inc. Aminophenyltetralin compounds
IT1065125B (it) 1975-08-20 1985-02-25 Boehringer Mannheim Gmbh Processo per mantenere costante l attivita di fosfatasi alcalina e siero di controllo contenente tale fosfatasi
DE2551208C3 (de) * 1975-11-14 1981-05-27 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation
US4040785A (en) 1976-10-18 1977-08-09 Technicon Instruments Corporation Lysable blood preservative composition
US4152208A (en) * 1977-03-29 1979-05-01 Hoffmann-La Roche Inc. Stabilized leucocytes
US4302355A (en) * 1977-08-01 1981-11-24 Warner-Lambert Company Platelet reference control
DE2828820A1 (de) * 1977-08-01 1979-02-08 Warner Lambert Co Verfahren zur herstellung einer stabilen blutplaettchensuspension und nach dem verfahren erhaltene stabile blutplaettchensuspension
US4324687A (en) 1979-02-15 1982-04-13 Louderback Allan Lee Blood biochemistry control standard
DE2949824A1 (de) * 1979-12-12 1981-07-02 Marianne Dr. 5000 Köln Sehrbundt Verfahren zur stabilisierung von lymphozyten/thrombozytennmischsuspensionen
US4346018A (en) 1980-06-16 1982-08-24 Coulter Electronics, Inc. Multi-purpose blood diluent and lysing agent for differential determination of lymphoid-myeloid population of leukocytes
US4405719A (en) * 1981-05-29 1983-09-20 Coulter Electronics, Inc. Method of stabilizing platelets for determining multiple platelet parameters in reference control and calibrator compositions; diluents therefor; and combination stabilization procedures
US4704352A (en) 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
JPH06100606B2 (ja) 1985-08-08 1994-12-12 リス、エ−ベルハルト 採取血中のグルコース含量の低減防止法
US4675185A (en) * 1985-12-06 1987-06-23 Baxter Travenol Laboratories, Inc. Solution for stabilizing red blood cells during storage
US4729959A (en) 1986-02-24 1988-03-08 Streck Laboratories, Inc. Glucose reference control for glucose test strips
US4806343A (en) 1986-03-13 1989-02-21 University Of Southwestern Louisiana Cryogenic protectant for proteins
IT1188132B (it) * 1986-05-07 1987-12-30 Fameccanica Spa Procedimento e dispositivo per la produzione di film perforati particolarmente film perforati di materiale plastico per articoli igienico sanitari
US5250438A (en) 1990-05-09 1993-10-05 Streck Laboratories, Inc. Method for differential determination of white blood cells using diazolidinyl urea to stabilize white blood cells
SU1767436A1 (ru) 1990-05-22 1992-10-07 Черновицкий Государственный Университет Способ определени глюкозы в крови
US5260048A (en) 1991-05-08 1993-11-09 Streck Laboratories, Inc. Tissue fixative solution and method
US5270208A (en) * 1991-05-09 1993-12-14 Streck Laboratories, Inc. White blood cell hematology control
JPH0820452B2 (ja) 1991-12-16 1996-03-04 株式会社いかがく 血液中糖類の微生物による消費阻止方法
US5422277A (en) * 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
WO1993021928A1 (en) 1992-04-24 1993-11-11 Streck Laboratories, Inc. Liquid glucose control solution and process of making the same
US5407794A (en) * 1992-09-08 1995-04-18 Cytocolor Inc. Oxazine stained lymphocytes and method
CA2123227C (en) 1992-09-10 2009-04-28 Wayne L. Ryan Method and composition for preserving antigens and process for utilizing cytological material produced by same
FR2705359B1 (fr) * 1993-05-19 1995-08-18 Immunotech Sa Méthode de protection des cellules leucocytaires, composition protectrice, composition de sang protégée, et méthode d'analyse sanguine.
CA2166729A1 (en) 1993-07-05 1995-01-19 Vivian Granger Preparation and stabilisation of cells
DE69504646T2 (de) * 1994-04-05 1999-04-29 North Gen Hospital Nhs Trust Herstellung und stabilisierung von zellsuspensionen

Also Published As

Publication number Publication date
CA2166729A1 (en) 1995-01-19
WO1995001796A1 (en) 1995-01-19
DE708649T1 (de) 2001-09-20
BR9407003A (pt) 1996-03-26
FI960045A (fi) 1996-01-05
EP0708649B1 (de) 2003-05-28
JPH09503051A (ja) 1997-03-25
GB9413558D0 (en) 1994-08-24
DE69432751T2 (de) 2004-04-29
ES2197168T3 (es) 2004-01-01
FI960045A0 (fi) 1996-01-05
GB2279653B (en) 1998-02-11
NZ271318A (en) 1998-08-26
AU4441096A (en) 1996-06-06
EP0708649A1 (de) 1996-05-01
NO960049L (no) 1996-03-05
US6197539B1 (en) 2001-03-06
US6197540B1 (en) 2001-03-06
AU7490994A (en) 1995-02-06
AU700699B2 (en) 1999-01-14
ATE241368T1 (de) 2003-06-15
NO960049D0 (no) 1996-01-05
GB2279653A (en) 1995-01-11

Similar Documents

Publication Publication Date Title
ATE241368T1 (de) Präparation und stabilisation von zellen
CO4820440A1 (es) Composiciones que contienen adenovirus recombinantes concentrados
NO982732L (no) Ny fremgangsmÕte
KR920006007A (ko) 이식 물질
AU667530B2 (en) Removal of antibodies from blood-derived compositions while retaining coagulation factors
NO954957D0 (no) Synergistisk stabiliserte flytende enzymatiske blandinger
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
ATE17363T1 (de) Verfahren zur herstellung von hochelastischen schaeumen und alkoxysilicium-verbindung(en) als schaumstabilisatoren hierfuer.
DE3782427D1 (de) Verwendung einer adenosin, hypoxanthin und ribose enthaltender loesung zur schonung des herzens waehrend chirurgischer eingriffe.
DE2742529C2 (de) Leichte (B) Kettenfraktion von Plasmin und Verfahren zu deren Herstellung
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
ATE287255T1 (de) Stabile flüssigkeiten mit hohem glycerolgehalt, die sulfosuccinsäuremonoester enthalten
FI854926A (fi) Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler.
ES8506621A1 (es) Procedimiento de preparar nuevas bencensulfonil-lactamas
ATE78397T1 (de) Verwendung von p-chlorophenoxyazetat von n,ndimethylbiguanidzur behandlung von neuropathien und nervendegeneration.
JPS56106594A (en) Stabilizing method of plasminogen
DE3784528T2 (de) Zusammensetzung und verfahren zur stabilisierung von dinukleotiden.
BR0000707A (pt) Composição de fase aquosa contìnua, utilização de pelo menos um sequestrante associado a pelo menos um neutralizante, processo de estabilização do ácido l-2- oxotiazolidina 4-carboxìlico e utilização da composição
EA199900675A2 (ru) Полиморф моногидрата зополрестата
EP0351591A3 (de) 2-tert.-Butyl-4-chlor-5-(4-tert.-butylbenzylthio)-3-(2H) -pyridazinon zur Bekämpfung von Schnecken
SE7906137L (sv) Rening av faktor viii
DE60026292D1 (de) Eine stabilisierte isothiazolon-zusammensetzung und ein verfahren zur stabilisierung von isothiazolon
ATE235824T1 (de) Verfahren zur herstellung von polyvinylpyrrolidon-iod in wässriger lösung
SE9801705D0 (sv) Biologically active composition
JPS60185757A (ja) 尿素の安定化法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee